Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Multichannel tDCS Protocol vs Conventional and Sham tDCS for Clinical Use in Patients With Major Depressive Disorder

NCT06165445 is registered in ClinicalTrials.gov with The National Brain Mapping Laboratory (NBML) as lead sponsor.

NCT NCT06165445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06165445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Multichannel tDCS Protocol vs Conventional and Sham tDCS for Clinical Use in Patients With Major Depressive Disorder
Lead sponsor
The National Brain Mapping Laboratory (NBML)
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2021
Completion date
March 1, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, depressive disorder, psychiatric disorder